Evidence map›Paper›PMID 40709416›Full record

ArticleThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2025

[Endoscopic Management of Ampulla of Vater Tumors].

Jong Jin Hyun

Abstract readEnglish Abstract
In one paragraph

Article in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jong Jin HyunDivision of Gastroenterology, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.ORCID 0000-0002-5632-7091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of tumors of the ampulla of Vater ranges from palliative care to endoscopic papillectomy and surgical resection. Treatment decisions should be based on a comprehensive assessment of multiple factors, including the lesion characteristics (e.g., size, location, and evidence of malignancy), the patient's overall health status, individual preferences, and the availability of local expertise. When an endoscopic papillectomy is selected as the treatment modality, it must be performed by an experienced endoscopist, with careful patient selection and strict adherence to the established indications. The indications for endoscopic papillectomy may broaden with ongoing advances in endoscopic techniques and diagnostic imaging. Nevertheless, patient safety must remain the foremost concern, with the goal of achieving complete and safe tumor resection while minimizing morbidity and mortality.

Indexed as

Ampulla of VaterCommon Bile Duct NeoplasmsCholangiopancreatography, Endoscopic RetrogradeHumansAmpulla of Vater tumorEndoscopic papillectomyTherapy

Identifiers

PMID40709416
PMCPMC12305071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.